S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Devonian Health Group Targets NYSE American Listing

Clinical-stage biopharmaceutical firm Devonian Health Group is launching an underwritten public offering of common shares and warrants, a move designed to secure a listing on the NYSE American. The Québec-based company plans to trade under the symbols DHGR and DHGRW, pending final regulatory authorization and market conditions.

Devonian Health Group Targets NYSE American Listing
Photo: Bio & News

The offering, managed by ThinkEquity as the sole book-running manager, marks a transition for the company as it seeks to elevate its presence on the U.S. exchange. Until the offering is priced, Devonian’s common shares will remain quoted on the OTCQB Venture Market. Once the NYSE American listing is finalized, trading on the OTCQB will cease.

Devonian also plans to align its Canadian ticker symbol with its new U.S. branding. The firm intends to request a change from its current TSXV symbol, GSD, to DHGR. While registration statements have been filed with the SEC, the offering remains subject to the declaration of effectiveness and standard regulatory approval processes. The company explicitly noted that no securities will be sold to investors residing in Québec or elsewhere in Canada as part of this specific offering.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!